NIH-funded research R01 grant

How alcohol affects brain chemistry related to anxiety and stress

Official title: Alcohol-induced epigenetic reprogramming of PPAR-α affects allopregnanolone biosynthesis

Funded at University of Illinois at Chicago · NIH-10930029 · Data updated 2026-11-12

This study looks at how drinking alcohol affects the levels of a brain chemical that helps manage anxiety and stress, using rats to see how long-term drinking changes the way this chemical is made, with the hope of finding new ways to help people struggling with alcohol use and anxiety.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Illinois at Chicago
NIH-funded
Lab location1 site (Chicago, UNITED STATES)
Project startSeptember 20, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$359,775
NIH project number5R01AA030292-02
Project IDNIH-10930029 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with alcohol use disorder or those experiencing anxiety related to alcohol consumption.

Less likely to help

Patients who do not consume alcohol or do not have anxiety disorders may not benefit from this research.

What this research studies

This research investigates how alcohol consumption alters the production of a neurosteroid called allopregnanolone, which plays a crucial role in regulating anxiety and stress responses. Using a rodent model, the study examines the effects of chronic alcohol exposure on the expression of enzymes responsible for allopregnanolone biosynthesis and explores the underlying epigenetic changes. By understanding these mechanisms, the research aims to identify potential therapeutic targets for treating alcohol use disorder and related anxiety disorders.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for individuals struggling with alcohol dependence and anxiety disorders.

How similar studies have gone: Previous research has shown promising results in understanding the role of neurosteroids in anxiety and alcohol use, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Illinois at Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Pinna, Graziano — University of Illinois at Chicago
  • Study coordinator: Pinna, Graziano

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.